Specifications
Immunogen
Purified recombinant fragment of Human Apolipoprotein E expressed in E. Coli.
Applications
Application Notes
Suitable for use in ELISA (1:1,000) and immunohistochemistry, frozen sections (1:100).
Target
Alternative Names
APOE; apolipoprotein E; AD2, Alzheimer disease 2 (APOE*E4 associated, late onset); apo-E; apolipoprotein E3; AD2; LPG; LDLCQ5; MGC1571;
Product Background
Antigen Description
Mediates the binding, internalization, and catabolism of lipoprotein particles. It can serve as a ligand for the LDL (apo B/E) receptor and for the specific apo-E receptor (chylomicron remnant) of hepatic tissues.
Pathway
Alzheimers disease, organism-specific biosystem; Alzheimers disease, conserved biosystem; Chylomicron-mediated lipid transport, organism-specific biosystem; HDL-mediated lipid transport, organism-specific biosystem; Lipid digestion, mobilization, and transport, organism-specific biosystem; Lipoprotein metabolism, organism-specific biosystem; Metabolism, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-2367 in a publication?
Let us know and earn a reward for your research.